Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Depo-estradiol
2. Estradiol 17 Beta-cyclopentanepropionate
3. Estradiol 17 Beta-cyclopentylpropionate
4. Estradiol 17 Beta-cypionate
1. 313-06-4
2. Depofemin
3. Depoestradiol
4. Depo-estradiol
5. Depoestra
6. Estradep
7. Estrapo
8. Estro-depo
9. Dep-estro
10. Femogen Cyp
11. Depgynogen
12. Depoestradiol Cypionate
13. Beta-estradiol 17-cypionate
14. Estradiol 17-cypionate
15. Estradiol Cyclopentylpropionate
16. Estradiol (cypionate)
17. E. Ionate P.a.
18. Estradiol 17-cyclopentylpropionate
19. Depo-estradiol Cyclopentylpropionate
20. Nsc 3354
21. Estradiol Cipionate
22. Estradiol, 17-cyclopentanepropionate
23. Cyclopentanepropionic Acid, 17-ester With Estradiol
24. Nsc-3354
25. Estradiol Cypionate [usp]
26. 17.beta.-estradiol Cypionate
27. Estradiol 17.beta.-cypionate
28. 7e1dv054lo
29. Chebi:34745
30. Nsc3354
31. Estra-1,3,5(10)-triene-3,17-diol(17b)-, 17-cyclopentanepropanoate
32. Estradiol 17beta-cyclopentylpropionate
33. 17.beta.-estradiol Cyclopentylpropionate
34. Estradiol 17.beta.-cyclopentylpropionate
35. 17.beta.-estradiol Cyclopentanepropionate
36. Estradiol 17.beta.-cyclopentanepropanoate
37. Estradiol 17.beta.-cyclopentanepropionate
38. Pertradiol
39. 17.beta.-estradiol 17-cyclopentylpropionate
40. Dsstox_cid_2999
41. Estradiol Cypionate (usp)
42. Neoginon Depositum
43. Dsstox_rid_76824
44. Dsstox_gsid_22999
45. Ecp (van)
46. Estradiol 17beta-cypionate
47. [(8r,9s,13s,14s,17s)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
48. Cas-313-06-4
49. Smr000058700
50. Estradiol 17-cyclopentanepropionate
51. Einecs 206-237-8
52. Estradiol 17beta-cylopentylpropionate
53. Estradiol 17beta-cyclopentanepropionate
54. Brn 3171075
55. Unii-7e1dv054lo
56. Depestro
57. 17beta-estradiol 17-cyclopentylpropionate
58. Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate
59. Estradiol-cypionate
60. Ncgc00166134-01
61. Mfcd00056558
62. Depo-estradiol (tn)
63. Estradiol Cypionate Salt
64. Schembl41551
65. 4-09-00-00047 (beilstein Handbook Reference)
66. Mls000069763
67. Mls001074891
68. 17beta-estradiol 17-cypionate
69. Chembl1200973
70. Dtxsid4022999
71. Hms2234k11
72. Estradiol Cypionate [vandf]
73. (8r,9s,13s,14s,17s)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-17-yl 3-cyclopentylpropanoate
74. Bcp11930
75. Estradiol Cipionate [mart.]
76. Hy-b1100
77. Zinc3876078
78. Tox21_110003
79. Tox21_112331
80. Tox21_301818
81. Estra-1,3,5(10)-triene-3,17beta-diol 17-(cyclopentanepropionate)
82. Estradiol Cipionate [who-dd]
83. Estradiol Cypionate [usp-rs]
84. Estradioli Cypionas [who-ip]
85. S4046
86. (17beta)-3-hydroxyestra-1(10),2,4-trien-17-yl 3-cyclopentylpropanoate
87. Akos015895730
88. Cyclopentanepropionic Acid, 3-hydroxyestra-1,3,5(10)-trien-17beta-yl Ester
89. Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-cyclopentanepropanoate
90. Estra-1,3,5(10)-triene-3,17-diol, (17beta)-, 17-cyclopentanepropanoate
91. Tox21_112331_1
92. .beta.-estradiol 17-cypionate
93. Beta-estradiol 17-cyclopentylpropionate
94. Ccg-268613
95. Cs-4691
96. Db13954
97. Ks-5296
98. Estradiol 17.beta.-cylopentylpropionate
99. Estradiol Cypionate [orange Book]
100. Ncgc00013034-01
101. Ncgc00166134-02
102. Ncgc00166134-03
103. Ncgc00255333-01
104. (1s,11s,14s,15s,10r)-5-hydroxy-15-methyltetracyclo[8.7.0.0<2,7>.0<11,15>]hepta Deca-2,4,6-trien-14-yl 3-cyclopentylpropanoate
105. Nci60_002938
106. Estradiol Cypionate [usp Monograph]
107. Estradiol-17-cyclopentanepropionate
108. Lunelle Component Estradiol Cypionate
109. E0875
110. D04063
111. Estradiol Cypionate Component Of Lunelle
112. 313d064
113. Depo-testadiol Component Estradiol Cypionate
114. Q5401760
115. W-106910
116. Estradiol 17.beta.-cyclopentanepropanoate [mi]
117. Estradiol Cypionate Component Of Depo-testadiol
118. (17?)-3-hydroxyestra-1,3,5(10)-trien-17-yl 3-cyclopentylpropanoate
119. 17.beta.-[(3-cyclopentylpropanoyl)oxy]estra-1,3,5(10)-trien-3-ol
120. Estra-1,5(10)-triene-3,17-diol (17.beta.)-, 17-cyclopentanepropanoate
121. Estra-1,5(10)-triene-3,17-diol, (17.beta.)-, 17-cyclopentanepropanoate
122. Estradiol Cypionate, United States Pharmacopeia (usp) Reference Standard
123. (17.beta.)-estra-1,3,5(10)-triene-3,17-diol 17.beta.-cyclopentanepropanoate
124. Cyclopentanepropionic Acid, 3-hydroxyestra-1,3,5(10)-trien-17.beta.-yl Ester
125. Estra-1,3,5(10)-triene-3,17-diol, (17.beta.)-, 17-cyclopentanepropanoate
Molecular Weight | 396.6 g/mol |
---|---|
Molecular Formula | C26H36O3 |
XLogP3 | 7.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 396.26644501 g/mol |
Monoisotopic Mass | 396.26644501 g/mol |
Topological Polar Surface Area | 46.5 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 597 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Depo-Estradiol intramuscular depot injection is indicated for the treatment of moderate to severe vasomotor symptoms and hypoestrogenism due to hypogonadism.
FDA Label
Estrogen mediates its effects across the body through potent agonism of the Estrogen Receptor (ER), which is located in various tissues including in the breasts, uterus, ovaries, skin, prostate, bone, fat, and brain. Estradiol binds to both subtypes of the Estrogen Receptor: Estrogen Receptor Alpha (ER) and Estrogen Receptor Beta (ER). Estradiol also acts as a potent agonist of G Protein-coupled Estrogen Receptor (GPER), which has recently been recognized as a major mediator of estradiol's rapid cellular effects.
Contraceptive Agents, Hormonal
Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)
Contraceptive Agents, Female
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)
Absorption
When conjugated with aryl and alkyl groups for parenteral administration, the rate of absorption of oily preparations is slowed with a prolonged duration of action, such that a single intramuscular injection of estradiol valerate or estradiol cypionate is absorbed over several weeks.
Route of Elimination
Estradiol, estrone and estriol are excreted in the urine along with glucuronide and sulfate conjugates.
Volume of Distribution
The distribution of exogenous estrogens is similar to that of endogenous estrogens. Estrogens are widely distributed in the body and are generally found in higher concentrations in the sex hormone target organs.
Exogenous estrogens are metabolized in the same manner as endogenous estrogens. Circulating estrogens exist in a dynamic equilibrium of metabolic interconversions. These transformations take place mainly in the liver. Estradiol is converted reversibly to estrone, and both can be converted to estriol, which is the major urinary metabolite. Estrogens also undergo enterohepatic recirculation via sulfate and glucuronide conjugation in the liver, biliary secretion of conjugates into the intestine, and hydrolysis in the gut followed by reabsorption. In postmenopausal women, a significant proportion of the circulating estrogens exist as sulfate conjugates, especially estrone sulfate, which serves as a circulating reservoir for the formation of more active estrogens.
Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. Increases in the down-stream effects of ER binding reverses some of the symptoms of menopause and of hypoestrogenism, which are primarily caused by a loss of estrogenic activity.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Estradiol Cypionate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Estradiol Cypionate, including repackagers and relabelers. The FDA regulates Estradiol Cypionate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Estradiol Cypionate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Estradiol Cypionate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Estradiol Cypionate supplier is an individual or a company that provides Estradiol Cypionate active pharmaceutical ingredient (API) or Estradiol Cypionate finished formulations upon request. The Estradiol Cypionate suppliers may include Estradiol Cypionate API manufacturers, exporters, distributors and traders.
click here to find a list of Estradiol Cypionate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Estradiol Cypionate DMF (Drug Master File) is a document detailing the whole manufacturing process of Estradiol Cypionate active pharmaceutical ingredient (API) in detail. Different forms of Estradiol Cypionate DMFs exist exist since differing nations have different regulations, such as Estradiol Cypionate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Estradiol Cypionate DMF submitted to regulatory agencies in the US is known as a USDMF. Estradiol Cypionate USDMF includes data on Estradiol Cypionate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Estradiol Cypionate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Estradiol Cypionate suppliers with USDMF on PharmaCompass.
A Estradiol Cypionate CEP of the European Pharmacopoeia monograph is often referred to as a Estradiol Cypionate Certificate of Suitability (COS). The purpose of a Estradiol Cypionate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Estradiol Cypionate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Estradiol Cypionate to their clients by showing that a Estradiol Cypionate CEP has been issued for it. The manufacturer submits a Estradiol Cypionate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Estradiol Cypionate CEP holder for the record. Additionally, the data presented in the Estradiol Cypionate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Estradiol Cypionate DMF.
A Estradiol Cypionate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Estradiol Cypionate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Estradiol Cypionate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Estradiol Cypionate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Estradiol Cypionate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Estradiol Cypionate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Estradiol Cypionate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Estradiol Cypionate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Estradiol Cypionate suppliers with NDC on PharmaCompass.
Estradiol Cypionate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Estradiol Cypionate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Estradiol Cypionate GMP manufacturer or Estradiol Cypionate GMP API supplier for your needs.
A Estradiol Cypionate CoA (Certificate of Analysis) is a formal document that attests to Estradiol Cypionate's compliance with Estradiol Cypionate specifications and serves as a tool for batch-level quality control.
Estradiol Cypionate CoA mostly includes findings from lab analyses of a specific batch. For each Estradiol Cypionate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Estradiol Cypionate may be tested according to a variety of international standards, such as European Pharmacopoeia (Estradiol Cypionate EP), Estradiol Cypionate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Estradiol Cypionate USP).
LOOKING FOR A SUPPLIER?